Servier Ranked Among Top Companies Across Several Categories in 2024 PatientView Corporate Reputation of Pharma Survey
News
Servier to Acquire Exclusive Worldwide Rights of BioNova’s BN104, a potential best-in-class menin inhibitor
Servier Presentations at ASCO 2025 Reinforce Company Leadership in IDH-Mutated Cancers
Shining a Light on Chondrosarcoma: A Rare Disease with Urgent Needs
Servier’s Golden Ticket goes to Viska Bio for its innovative scientific approach in hard-to-treat cancers
For Tara Brown, National Blood Donor Month is the “Gift of Hope and Survival”
Vora Artwork by Yilin Zhu
Biopharma’s Best Kept Secret Opens its Doors to New Partners
Ragan Honors Servier’s Kelly Schlemm with Top Women in Communications Award